-
EdU Flow Cytometry Assay Kits (Cy3) for Prostate Cancer
2026-08-13
Translate BaP exposure studies into quantitative S-phase, tumor-cell, and immune-cell readouts with a denaturation-free click-chemistry workflow. The Cy3 assay supports multiplexed cell cycle analysis, genotoxicity testing, and pharmacodynamic experiments while preserving antigenicity for marker-based gating.
-
SP600125 JNK Inhibitor: Applied Workflows
2026-08-12
SP600125 enables time-resolved interrogation of JNK-dependent phosphorylation, apoptosis, and inflammatory signaling. This practical guide connects its established c-Jun and cytokine use cases with assay strategies inspired by recent trigeminal ganglion research, while clearly separating validated evidence from exploratory applications.
-
Recombinant Mouse M-CSF: Assay Design Guide
2026-08-12
Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) can do more than expand macrophages: it can define the cellular baseline for mechanistic studies. This guide connects PM2021 biology with macrophage metabolism and fibrosis assay design while separating differentiation effects from disease-specific signaling.
-
Tamoxifen Workflows for CreER and Cancer Research
2026-08-11
Explore practical Tamoxifen workflows for temporally controlled CreER-mediated gene knockout, breast cancer research, and signaling assays. This guide also translates a SERM antimalarial study into hypothesis-driven assay design while emphasizing solubility control, appropriate comparators, and reproducible troubleshooting.
-
Deferasirox, Mitochondrial ROS, and Myeloid Maturation
2026-08-11
This 2024 short report shows that deferasirox has differentiation-stage-specific effects on mitochondrial reactive oxygen species, NF-κB-related transcription, and myeloid maturation. By combining murine and human models with hypoxia experiments and single-cell transcriptomics, the study provides a mechanistic framework for understanding both hematologic improvement and possible neutrophil-related toxicity.
-
γH2AX DNA Damage Detection Kit for DSB Assays
2026-08-10
Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved DNA double-strand break measurements with a red γ-H2AX signal and blue nuclear counterstain. This workflow shows how to optimize staining, quantify foci, and connect early DNA damage with apoptosis and repair outcomes.
-
Cy3-UTP: Reading RNA in Condensate Biology
2026-08-09
Cy3-UTP enables fluorescent RNA production for imaging, detection, and RNA-protein interaction studies. This article explains how to use Cy3-labeled transcripts to distinguish RNA localization from mechanistic evidence in phase-separated viral replication-organelle models.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-08
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that are difficult to separate with conventional Tris-SDS-PAGE. It is suitable for research workflows using denaturing or non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.
-
Lysis Buffer for Rapid Mouse Genotyping Workflows
2026-08-07
Build faster, more consistent mouse genotyping workflows with a lysis buffer designed for tail, toe, and ear tissue digestion. This guide connects practical DNA-release steps with experimental planning inspired by a six-gene colorectal cancer study, while clearly separating validated product use from exploratory applications.
-
Clodronate Liposomes for In Vivo Macrophage Depletion: Workf
2026-08-07
Clodronate Liposomes enable precise, reproducible in vivo macrophage depletion, empowering advanced studies of immune cell modulation in cancer and inflammation models. Their versatility in administration and robust workflow optimization set them apart for dissecting tumor microenvironment and immunotherapy resistance mechanisms.
-
AP20187: Driving Precision in Conditional Gene Therapy Resea
2026-08-06
Explore how AP20187, a leading chemical inducer of dimerization, empowers translational researchers to achieve programmable control over gene expression and cell signaling. This thought-leadership article examines mechanistic insights, experimental best practices, and the strategic significance of AP20187 for advancing regulated cell therapy and disease modeling, with a focus on emerging pain and metabolic research.
-
Applied Workflows for Cyclic Pifithrin-α Hydrobromide in p53
2026-08-06
Cyclic Pifithrin-α hydrobromide enables precise, selective inhibition of p53 signaling—empowering researchers to dissect DNA damage responses, model apoptosis inhibition, and optimize radioprotective assays. This article bridges current cancer and neuroinflammatory research, delivering actionable workflows, troubleshooting strategies, and new insights for advanced experimentation.
-
MOG (35-55) Peptide: Advanced EAE Workflows & Troubleshootin
2026-08-05
Leverage the MOG (35-55) myelin oligodendrocyte glycoprotein peptide to induce robust, reproducible experimental autoimmune encephalomyelitis (EAE) for multiple sclerosis research. This guide translates new mechanistic insights and hands-on troubleshooting into strategic protocol enhancements, unlocking translational neuroimmunology with APExBIO’s gold-standard reagent.
-
Technical Application Guide: Anti-HMGB1 Rabbit Monoclonal An
2026-08-05
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific detection of HMGB1 protein in human, mouse, and rat research samples across Western blot, immunohistochemistry, and flow cytometry workflows. It is not validated for diagnostic or therapeutic use and should be used solely for controlled scientific research with strict adherence to recommended protocols.
-
CCL7+ Macrophages Drive Immunotherapy Resistance in CRC
2026-08-04
This study uncovers how CCL7-expressing tumor-associated macrophages (TAMs) orchestrate immune evasion in colorectal cancer, limiting the response to immune checkpoint inhibitors. By elucidating the metabolic and signaling pathways involved, the work highlights CCL7 as a tractable target to improve immunotherapy efficacy.